Cirtran Overview
Get informed when a big investor buys or sells
+ Follow-9.26%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for CIRX is -9.26%. That is below the sector sector average of 11.64%. Investors often review this figure alongside Cirtran's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, CIRX currently prints -9.26% for ROE, while the sector average sits near 11.64%. That is roughly 179.6% below the sector mean. Large gaps often invite a closer look at Cirtran's growth, margins, and balance sheet.
Return on Equity shows how effectively Cirtran converts resources into returns. At -9.26%, CIRX may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CIRX's ROE (-9.26%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
